A Novel iRFP-Incorporated in vivo Murine Atherosclerosis Imaging System
Abstract By using near-infrared fluorescent protein (iRFP)-expressing hematopoietic cells, we established a novel, quantitative, in vivo, noninvasive atherosclerosis imaging system. This murine atherosclerosis imaging approach targets macrophages expressing iRFP in plaques. Low-density lipoprotein r...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4d61aeb86c6e4b90a0b29fc94a27c589 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:4d61aeb86c6e4b90a0b29fc94a27c589 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:4d61aeb86c6e4b90a0b29fc94a27c5892021-12-02T11:40:46ZA Novel iRFP-Incorporated in vivo Murine Atherosclerosis Imaging System10.1038/s41598-018-32456-52045-2322https://doaj.org/article/4d61aeb86c6e4b90a0b29fc94a27c5892018-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-32456-5https://doaj.org/toc/2045-2322Abstract By using near-infrared fluorescent protein (iRFP)-expressing hematopoietic cells, we established a novel, quantitative, in vivo, noninvasive atherosclerosis imaging system. This murine atherosclerosis imaging approach targets macrophages expressing iRFP in plaques. Low-density lipoprotein receptor-deficient (LDLR −/− ) mice transplanted with beta-actin promoter-derived iRFP transgenic (TG) mouse bone marrow (BM) cells (iRFP → LDLR −/− ) were used. Atherosclerosis was induced by a nonfluorescent 1.25% cholesterol diet (HCD). Atherosclerosis was compared among the three differently induced mouse groups. iRFP → LDLR −/− mice fed a normal diet (ND) and LDLR −/− mice transplanted with wild-type (WT) BM cells were used as controls. The in vivo imaging system (IVIS) detected an enhanced iRFP signal in the thoracic aorta of HCD-fed iRFP → LDLR −/− mice, whereas iRFP signals were not observed in the control mice. Time-course imaging showed a gradual increase in the signal area, which was correlated with atherosclerotic plaque progression. Oil red O (ORO) staining of aortas and histological analysis of plaques confirmed that the detected signal was strictly emitted from plaque-positive areas of the aorta. Our new murine atherosclerosis imaging system can noninvasively image atherosclerotic plaques in the aorta and generate longitudinal data, validating the ability of the system to monitor lesion progression.Kaushalya KulathungaMichito HamadaYukiko HiraishiMao OtakeMai Thi Nhu TranOlivia ChengJunko TanakaTomoki SakasaiShota SakaguchiYuka SugiyamaBernd K. FleischmannSatoru TakahashiYoshihiro MiwaNature PortfolioarticleIn Vivo Imaging System (IVIS)Near-infrared Fluorescent ProteinIVIS ImagesPlaque MacrophagesAtherosclerosis InductionMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-11 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
In Vivo Imaging System (IVIS) Near-infrared Fluorescent Protein IVIS Images Plaque Macrophages Atherosclerosis Induction Medicine R Science Q |
spellingShingle |
In Vivo Imaging System (IVIS) Near-infrared Fluorescent Protein IVIS Images Plaque Macrophages Atherosclerosis Induction Medicine R Science Q Kaushalya Kulathunga Michito Hamada Yukiko Hiraishi Mao Otake Mai Thi Nhu Tran Olivia Cheng Junko Tanaka Tomoki Sakasai Shota Sakaguchi Yuka Sugiyama Bernd K. Fleischmann Satoru Takahashi Yoshihiro Miwa A Novel iRFP-Incorporated in vivo Murine Atherosclerosis Imaging System |
description |
Abstract By using near-infrared fluorescent protein (iRFP)-expressing hematopoietic cells, we established a novel, quantitative, in vivo, noninvasive atherosclerosis imaging system. This murine atherosclerosis imaging approach targets macrophages expressing iRFP in plaques. Low-density lipoprotein receptor-deficient (LDLR −/− ) mice transplanted with beta-actin promoter-derived iRFP transgenic (TG) mouse bone marrow (BM) cells (iRFP → LDLR −/− ) were used. Atherosclerosis was induced by a nonfluorescent 1.25% cholesterol diet (HCD). Atherosclerosis was compared among the three differently induced mouse groups. iRFP → LDLR −/− mice fed a normal diet (ND) and LDLR −/− mice transplanted with wild-type (WT) BM cells were used as controls. The in vivo imaging system (IVIS) detected an enhanced iRFP signal in the thoracic aorta of HCD-fed iRFP → LDLR −/− mice, whereas iRFP signals were not observed in the control mice. Time-course imaging showed a gradual increase in the signal area, which was correlated with atherosclerotic plaque progression. Oil red O (ORO) staining of aortas and histological analysis of plaques confirmed that the detected signal was strictly emitted from plaque-positive areas of the aorta. Our new murine atherosclerosis imaging system can noninvasively image atherosclerotic plaques in the aorta and generate longitudinal data, validating the ability of the system to monitor lesion progression. |
format |
article |
author |
Kaushalya Kulathunga Michito Hamada Yukiko Hiraishi Mao Otake Mai Thi Nhu Tran Olivia Cheng Junko Tanaka Tomoki Sakasai Shota Sakaguchi Yuka Sugiyama Bernd K. Fleischmann Satoru Takahashi Yoshihiro Miwa |
author_facet |
Kaushalya Kulathunga Michito Hamada Yukiko Hiraishi Mao Otake Mai Thi Nhu Tran Olivia Cheng Junko Tanaka Tomoki Sakasai Shota Sakaguchi Yuka Sugiyama Bernd K. Fleischmann Satoru Takahashi Yoshihiro Miwa |
author_sort |
Kaushalya Kulathunga |
title |
A Novel iRFP-Incorporated in vivo Murine Atherosclerosis Imaging System |
title_short |
A Novel iRFP-Incorporated in vivo Murine Atherosclerosis Imaging System |
title_full |
A Novel iRFP-Incorporated in vivo Murine Atherosclerosis Imaging System |
title_fullStr |
A Novel iRFP-Incorporated in vivo Murine Atherosclerosis Imaging System |
title_full_unstemmed |
A Novel iRFP-Incorporated in vivo Murine Atherosclerosis Imaging System |
title_sort |
novel irfp-incorporated in vivo murine atherosclerosis imaging system |
publisher |
Nature Portfolio |
publishDate |
2018 |
url |
https://doaj.org/article/4d61aeb86c6e4b90a0b29fc94a27c589 |
work_keys_str_mv |
AT kaushalyakulathunga anovelirfpincorporatedinvivomurineatherosclerosisimagingsystem AT michitohamada anovelirfpincorporatedinvivomurineatherosclerosisimagingsystem AT yukikohiraishi anovelirfpincorporatedinvivomurineatherosclerosisimagingsystem AT maootake anovelirfpincorporatedinvivomurineatherosclerosisimagingsystem AT maithinhutran anovelirfpincorporatedinvivomurineatherosclerosisimagingsystem AT oliviacheng anovelirfpincorporatedinvivomurineatherosclerosisimagingsystem AT junkotanaka anovelirfpincorporatedinvivomurineatherosclerosisimagingsystem AT tomokisakasai anovelirfpincorporatedinvivomurineatherosclerosisimagingsystem AT shotasakaguchi anovelirfpincorporatedinvivomurineatherosclerosisimagingsystem AT yukasugiyama anovelirfpincorporatedinvivomurineatherosclerosisimagingsystem AT berndkfleischmann anovelirfpincorporatedinvivomurineatherosclerosisimagingsystem AT satorutakahashi anovelirfpincorporatedinvivomurineatherosclerosisimagingsystem AT yoshihiromiwa anovelirfpincorporatedinvivomurineatherosclerosisimagingsystem AT kaushalyakulathunga novelirfpincorporatedinvivomurineatherosclerosisimagingsystem AT michitohamada novelirfpincorporatedinvivomurineatherosclerosisimagingsystem AT yukikohiraishi novelirfpincorporatedinvivomurineatherosclerosisimagingsystem AT maootake novelirfpincorporatedinvivomurineatherosclerosisimagingsystem AT maithinhutran novelirfpincorporatedinvivomurineatherosclerosisimagingsystem AT oliviacheng novelirfpincorporatedinvivomurineatherosclerosisimagingsystem AT junkotanaka novelirfpincorporatedinvivomurineatherosclerosisimagingsystem AT tomokisakasai novelirfpincorporatedinvivomurineatherosclerosisimagingsystem AT shotasakaguchi novelirfpincorporatedinvivomurineatherosclerosisimagingsystem AT yukasugiyama novelirfpincorporatedinvivomurineatherosclerosisimagingsystem AT berndkfleischmann novelirfpincorporatedinvivomurineatherosclerosisimagingsystem AT satorutakahashi novelirfpincorporatedinvivomurineatherosclerosisimagingsystem AT yoshihiromiwa novelirfpincorporatedinvivomurineatherosclerosisimagingsystem |
_version_ |
1718395514314031104 |